PDS Biotechnology (PDSB) Other Non Operating Income (2019)
PDS Biotechnology's (PDSB) quarterly Other Non Operating Income came in at $1.4 million in Q4 2019, up 566.15% on a QoQ basis from $209449.0 in Q2 2019.
PDS Biotechnology (PDSB) Other Non Operating Income (2019) Analysis & Trends
PDS Biotechnology (PDSB) has 1 years of Other Non Operating Income data on file, last reported at $1.4 million in Q4 2019.
- Quarterly Other Non Operating Income changed N/A year-over-year to $1.4 million in Q4 2019, while the trailing twelve-month figure through Sep 2020 was $1.4 million (down 88.31% YoY) and the FY2019 annual result came in at $13.3 million, changed N/A from the prior year.
- Other Non Operating Income climbed to $1.4 million in Q4 2019, from $209449.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $11.7 million in Q1 2019 to a low of $209449.0 in Q2 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1.40 Mn |
| Jun 30, 2019 | 209,449.00 |
| Mar 31, 2019 | 11.73 Mn |